Abstract
O-010 KRAS and BRAF gene subgroup analysis in the Phase 3 RECOURSE trial of TAS-102 versus placebo in patients with metastatic colorectal cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have